Cathal Friel
Fondateur chez HVIVO PLC
Fortune : 13 M $ au 30/04/2024
Profil
Mr. Cathal M.
Friel is a Non-Executive Director at European Green Transition Plc, an Executive Chairman at Poolbeg Pharma Plc, a Non-Executive Chairman at hVIVO Ltd., a Non-Executive Chairman at hVIVO PLC and a Managing Director at Raglan Capital Ltd.
He is on the Board of Directors at European Green Transition Plc and PrEP Biopharm Ltd.
Mr. Friel was previously employed as a Chief Executive Officer by Open Orphan DAC, a Chief Executive Officer & Director by Venn Life Sciences Holdings Plc, a Non-Executive Director by T5 Oil & Gas Ltd., a Non-Executive Chairman by Fastnet Equity Plc, a Non-Executive Director by Amryt Pharma Plc /Old/, a Chairman by Fastnet Equity Plc, and a Founding Director by Merrion Stockbrokers Ltd.
He received his MBA from the University of Ulster.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HVIVO PLC
3,11% | 14/02/2024 | 21 159 177 ( 3,11% ) | 7 M $ | 30/04/2024 |
POOLBEG PHARMA PLC
7,44% | 19/02/2024 | 37 219 757 ( 7,44% ) | 6 M $ | 30/04/2024 |
Postes actifs de Cathal Friel
| Sociétés | Poste | Début |
|---|---|---|
| HVIVO PLC | Fondateur | 01/02/2011 |
| HVIVO PLC | Président | 01/04/2020 |
| POOLBEG PHARMA PLC | Fondateur | 01/09/2020 |
Raglan Capital Ltd.
 Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Directeur Général | 01/01/2007 |
PrEP Biopharm Ltd.
 PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Directeur/Membre du Conseil | 10/07/2020 |
Anciens postes connus de Cathal Friel
| Sociétés | Poste | Fin |
|---|---|---|
T5 Oil & Gas Ltd.
 T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 09/08/2018 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Fondateur | 28/03/2017 |
Fastnet Equity Plc
 Fastnet Equity Plc Financial ConglomeratesFinance Fastnet Equity Plc engages in exploration of oil and gas. It operates through the following geographical segments: UK and Ireland; and Morocco. The company was founded in December 20, 2004 and is headquartered in Stockport, the United Kingdom. | Fondateur | - |
Merrion Stockbrokers Ltd.
 Merrion Stockbrokers Ltd. Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Merrion Stockbrokers Ltd. is a brokerage firm that provides brokerage services. The company is based in Dublin, Ireland. The Irish company was founded in 1999. Johnny Lynch has been the CEO of the company since 2015. | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Cathal Friel
| University of Ulster | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HVIVO PLC | Commercial Services |
| POOLBEG PHARMA PLC | Health Technology |
| Entreprise privées | 9 |
|---|---|
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Merrion Stockbrokers Ltd.
Merrion Stockbrokers Ltd. Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Merrion Stockbrokers Ltd. is a brokerage firm that provides brokerage services. The company is based in Dublin, Ireland. The Irish company was founded in 1999. Johnny Lynch has been the CEO of the company since 2015. | Finance |
Fastnet Equity Plc
Fastnet Equity Plc Financial ConglomeratesFinance Fastnet Equity Plc engages in exploration of oil and gas. It operates through the following geographical segments: UK and Ireland; and Morocco. The company was founded in December 20, 2004 and is headquartered in Stockport, the United Kingdom. | Finance |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Finance |
Venn Life Sciences Holdings Plc
 Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Health Services |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Energy Minerals |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Open Orphan DAC
 Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Technology Services |
